2009
DOI: 10.1007/978-0-387-73657-0_7
|View full text |Cite
|
Sign up to set email alerts
|

High Throughput Solid Phase Parallel Synthesis of Macrocyclic Peptidomimetics

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2012
2012
2023
2023

Publication Types

Select...
4
1
1

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 8 publications
0
4
0
Order By: Relevance
“…352,353 Noteworthy aspects of the solid phase process, which yielded a screening library of over 40,000 diverse compounds (general structure 269, Figure 11.19, site of cyclization and reagent employed indicated), were (a) the use of a thioester linker that enabled cyclization to form the macrolactam to occur simultaneous with cleavage from the resin (''cyclization-release'' as described in Section 11.2), 54 (b) the formation of the C-N sp 3 bond between the amino acid chain and the tether utilized an N-benzothiazole-2-sulphonyl (Bts) 354 moiety for dual roles, first as protection of the amine and then for activation towards use in a Fukuyama-Mitsunobu reaction, and (c) the optional addition of silver to assist with difficult cyclizations. 355 Compounds of this type were also accessed using RCM.…”
Section: Synthesis At Scalementioning
confidence: 98%
“…352,353 Noteworthy aspects of the solid phase process, which yielded a screening library of over 40,000 diverse compounds (general structure 269, Figure 11.19, site of cyclization and reagent employed indicated), were (a) the use of a thioester linker that enabled cyclization to form the macrolactam to occur simultaneous with cleavage from the resin (''cyclization-release'' as described in Section 11.2), 54 (b) the formation of the C-N sp 3 bond between the amino acid chain and the tether utilized an N-benzothiazole-2-sulphonyl (Bts) 354 moiety for dual roles, first as protection of the amine and then for activation towards use in a Fukuyama-Mitsunobu reaction, and (c) the optional addition of silver to assist with difficult cyclizations. 355 Compounds of this type were also accessed using RCM.…”
Section: Synthesis At Scalementioning
confidence: 98%
“…Yet another area of Éric’s work was the permeability of macrocycles and guanidine-rich transporters with a twin focus on (1) understanding the structure–permeability and structure–property relationships of semipeptidic macrocycles and (2) modulating guanidine-rich transporter structure to gain better insight into cellular-membrane chemistry and to help design selective agents to shuttle cargo into cells (Figure ). Éric coauthored several reviews on the impact of macrocycles in drug discovery and was a guest editor of Practical Medicinal Chemistry with Macrocycles . …”
Section: A Medicinal Chemist Pioneering Macrocyclic Researchmentioning
confidence: 99%
“…However, a conventional peptoid synthesizer based on a peptide synthesizer does not allow for the synthesis of large split and mix libraries. The IRORI technology is a commercially available format of nano- up to macro-reactors that allows for maximizing the benefits of split and mix synthesis while enabling the automated production of larger amounts of single compounds per reactor [30,31,32,33,34,35,36] (Figure 1). This technology supports the synthesis of large and chemically diverse libraries by the use of directed sorting technology based on glass coated radiofrequency (Rf) tags embedded in the reactors.…”
Section: Introductionmentioning
confidence: 99%
“…Here, we established the submonomer-based solid phase synthesis of a “proof of principle” CPPo library in IRORI MiniKans [31,32,33,34,35,36]. Eventually, the CPPo library was applied to HeLa cells for the screening of organelle targeting CPPos.…”
Section: Introductionmentioning
confidence: 99%